| Application no. and date | 06753710.0 (espacenet) (Federated) (European Patent Register), 20060518 | | Patent/reg. no. and date | DK/EP 1888578, 20111130 | | Publication date | 20080220 | | Priority no. and date | GB 0510390, 20050520 | | EP pub. no. and date |
EP 1888578 20080220 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 143301 | | Inventor | GARCIA-ECHEVERRIA, Carlos, Engelgasse 126
CH-4052 Basel, CH,
STAUFFER, Frédéric, Sonnenhofring 10
CH-4153 Reinach, CH,
FURET, Pascal, Rue du Riegelsbourg 24
F-68800 Thann, FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4188 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | | Title | 2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolinyl)-phenyl]-propionitril som lipidkinaseinhibitor | | Int. application no. | EP2006004725 | | Int. publication no. | WO2006122806 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
